Boston, MA, United States of America

Jan Unkelbach


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Boston, MA (US) (2020)
  • Cambridge, MA (US) (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jan Unkelbach: Innovator in Radiotherapy Planning

Introduction

Jan Unkelbach is a notable inventor based in Boston, MA (US), recognized for his contributions to the field of radiotherapy planning. With a total of 2 patents, he has made significant advancements that enhance the precision and effectiveness of radiation treatment.

Latest Patents

Unkelbach's latest patents include a "Fractionation Selection Tool in Radiotherapy Planning" and "Volumetric Modulated Arc Therapy (VMAT) with Non-Coplanar Trajectories." The fractionation selection tool optimizes radiation therapy by receiving inputs such as radiation dose distribution, maximum and minimum fractions, and BED constraints for organs-at-risk. It displays a 2D graph that illustrates the relationship between various parameters, allowing for real-time updates based on new fractionation schemes. The VMAT method involves selecting non-coplanar beam directions through a fluence optimization process, ultimately generating a VMAT radiation plan that incorporates non-coplanar trajectories.

Career Highlights

Throughout his career, Jan Unkelbach has worked with prominent organizations, including Koninklijke Philips Corporation N.V. and The General Hospital Corporation. His work has focused on improving radiotherapy techniques, making significant contributions to patient care and treatment outcomes.

Collaborations

Unkelbach has collaborated with esteemed colleagues such as Matthieu Frédéric Bal and David J Papp, further enhancing the impact of his innovations in the field of radiotherapy.

Conclusion

Jan Unkelbach's work in radiotherapy planning exemplifies the importance of innovation in medical technology. His patents and collaborations reflect a commitment to improving patient outcomes through advanced treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…